Related Experiment Videos
Alveolar soft-part sarcoma: a hormone-sensitive tumour?
J A Pang1, T F Yeung, C S Cockram
1Department of Medicine, Chinese University, Prince of Wales Hospital, Shatin, Hong Kong.
Postgraduate Medical Journal
|May 1, 1988
Summary
Alveolar soft-part sarcoma, a rare cancer, typically has poor outcomes. This case study suggests hormonal manipulation might be a viable treatment option, showing prolonged survival in a patient with lung metastases.
Area of Science:
- Oncology
- Medical Research
Background:
- Alveolar soft-part sarcoma (ASPS) is a rare, slow-growing malignant tumor with frequent lung metastasis.
- Current treatments like radiotherapy and chemotherapy show limited efficacy, with a poor prognosis for patients with metastases.
Observation:
- A patient with ASPS survived for 9 years after the detection of pulmonary metastases, exceeding the typical 4-year survival rate.
- Initial cytotoxic chemotherapy was ineffective for this patient.
Findings:
- During treatment with Chinese herbs, the patient experienced galactorrhea and amenorrhea, likely due to drug-induced hyperprolactinemia.
- Remarkably, the patient's lung metastases regressed during this period, suggesting a potential link between hormonal changes and tumor response.
Implications:
- The findings suggest that alveolar soft-part sarcoma may possess hormone sensitivity.
- Hormonal manipulation could be a potential alternative therapeutic strategy for ASPS, warranting further investigation.